[go: up one dir, main page]

DK2087890T3 - Præparat med vedvarende frigørelse til vævsregenereringsterapi - Google Patents

Præparat med vedvarende frigørelse til vævsregenereringsterapi

Info

Publication number
DK2087890T3
DK2087890T3 DK07830074.6T DK07830074T DK2087890T3 DK 2087890 T3 DK2087890 T3 DK 2087890T3 DK 07830074 T DK07830074 T DK 07830074T DK 2087890 T3 DK2087890 T3 DK 2087890T3
Authority
DK
Denmark
Prior art keywords
sustained release
tissue regeneration
release preparation
regeneration therapy
therapy
Prior art date
Application number
DK07830074.6T
Other languages
English (en)
Inventor
Yoshiki Sakai
Takahiro Uchida
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK2087890T3 publication Critical patent/DK2087890T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK07830074.6T 2006-10-19 2007-10-18 Præparat med vedvarende frigørelse til vævsregenereringsterapi DK2087890T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006285357 2006-10-19
PCT/JP2007/070340 WO2008047863A1 (en) 2006-10-19 2007-10-18 Sustained release preparation for tissue regeneration therapy

Publications (1)

Publication Number Publication Date
DK2087890T3 true DK2087890T3 (da) 2014-05-19

Family

ID=39314081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07830074.6T DK2087890T3 (da) 2006-10-19 2007-10-18 Præparat med vedvarende frigørelse til vævsregenereringsterapi

Country Status (8)

Country Link
US (1) US8617614B2 (da)
EP (1) EP2087890B1 (da)
JP (1) JP5423003B2 (da)
DK (1) DK2087890T3 (da)
ES (1) ES2459743T3 (da)
PL (1) PL2087890T3 (da)
PT (1) PT2087890E (da)
WO (1) WO2008047863A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393321T3 (es) 2002-10-10 2012-12-20 Ono Pharmaceutical Co., Ltd. Promotores de la producción de factores de reparación endógenos
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
WO2014046065A1 (ja) 2012-09-21 2014-03-27 国立大学法人大阪大学 心筋・血管再生デバイスとしての重症心不全治療材
US20150272874A1 (en) 2012-10-29 2015-10-01 Cardio Incorporated Pulmonary disease-specific therapeutic agent
JP6449166B2 (ja) * 2013-10-15 2019-01-09 小野薬品工業株式会社 薬剤溶出性ステントグラフト
EP3569249A4 (en) * 2016-12-27 2020-11-11 Osaka University PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF REFRACTORY HEART DISEASE
WO2019102606A1 (ja) 2017-11-27 2019-05-31 国立大学法人大阪大学 疾患部位特異的リポソーム製剤
WO2020082083A1 (en) * 2018-10-19 2020-04-23 South Dakota Board Of Regents Methods and compositions for localized intraductal drug delivery to the breast and regional lymph nodes
US11717656B2 (en) * 2019-03-20 2023-08-08 Gyros ACMI Inc. Delivery of mixed phase media for the treatment of the anatomy
CN111035626B (zh) * 2019-12-24 2021-08-06 山东大学第二医院 一种载罗氟司特药物的plga生物降解缓释制剂的制备方法
CN114699535B (zh) * 2022-01-29 2024-05-03 西北工业大学 一种微凝胶包覆金属有机框架的多效协同关节润滑剂及其制备方法
US20240091163A1 (en) 2022-09-09 2024-03-21 Ricoh Company, Ltd. Sustained releasing particle and method of producing sustained releasing particle
JP2025164729A (ja) 2024-04-18 2025-10-30 株式会社リコー 樹脂粒子、及び樹脂粒子の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191137B1 (ko) 1992-07-21 1999-06-15 사노 가즈오 옥심 유도체
JP2992677B2 (ja) 1995-06-05 1999-12-20 武田薬品工業株式会社 骨形成促進医薬組成物
MX9700850A (es) 1995-06-09 1997-09-30 Euro Celtique Sa Formulaciones y metodos para proporcionar anestesia local prolongada.
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
ES2393321T3 (es) * 2002-10-10 2012-12-20 Ono Pharmaceutical Co., Ltd. Promotores de la producción de factores de reparación endógenos
CA2518223A1 (en) * 2003-03-26 2004-10-07 Ltt Bio-Pharma Co., Ltd. Intravenous nanoparticles for targeting drug delivery and sustained drug release

Also Published As

Publication number Publication date
PL2087890T3 (pl) 2014-08-29
EP2087890A1 (en) 2009-08-12
PT2087890E (pt) 2014-05-12
EP2087890B1 (en) 2014-03-05
ES2459743T3 (es) 2014-05-12
US20100323026A1 (en) 2010-12-23
JPWO2008047863A1 (ja) 2010-02-25
JP5423003B2 (ja) 2014-02-19
US8617614B2 (en) 2013-12-31
EP2087890A4 (en) 2010-10-20
WO2008047863A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
DK2087890T3 (da) Præparat med vedvarende frigørelse til vævsregenereringsterapi
IL250734A0 (en) Transdermal therapeutic system
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK3457135T3 (da) Behandlingsmuligheder til fabrys sygdom
PT2055308T (pt) Medicamento para promover a regeneração funcional de tecido danificado
DK1924151T3 (da) Oral frigivelsessystem med styret frigivelse
EP2119444A4 (en) THERAPEUTIC AGENT FOR PAIN
BRPI0916931A2 (pt) agentes terapêuticos
GB0609492D0 (en) Therapeutic agents
DK1959991T3 (da) Terapeutisk vaccine
DK2144905T3 (da) Terapeutiske midler
DK2035369T3 (da) Terapeutiske
GB0608928D0 (en) Therapeutic agents
HUE062920T2 (hu) Eljárások vakcina beadására
GB0601962D0 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0616214D0 (en) Therapeutic Agents
DK2041128T3 (da) Substituerede gamma-lactamer som terapeutiske agenser
BRPI0818598A2 (pt) agentes terapêuticos - 802
BRPI0716742A2 (pt) Lactamas terapêuticas
EP2061502A4 (en) CARBOHYDRATE-BASED VACCINES FOR HLV
ZA200809004B (en) Autodestructive transdermal therapeutic system
EP1968603A4 (en) THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS
GB0611152D0 (en) Therapeutic agents
ZA200900035B (en) Prophylactic or therapeutic agent for viral disease